| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 54 | 2023 |
| Identifying inequalities in childhood immunisation uptake and timeliness in southeast Scotland, 2008–2018: A retrospective cohort study EA Haider, LJ Willocks, N Anderson Vaccine 37 (37), 5614-5624, 2019 | 22 | 2019 |
| Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review KG Young, EH McInnes, RJ Massey, AR Kahkoska, SJ Pilla, S Raghavan, ... Communications medicine 3 (1), 131, 2023 | 5 | 2023 |
| Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors KG Young, EH McInnes, RJ Massey, AR Kahkohska, SJ Pilla, ... medRxiv, 2023 | 5 | 2023 |
| Precision medicine in diabetes AY Dawed, E Haider, ER Pearson Precision Medicine, 107-129, 2022 | 2 | 2022 |
| Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes P Cardoso, KG Young, ATN Nair, R Hopkins, AP McGovern, E Haider, ... medRxiv, 2023.08. 04.23293636, 2023 | 1 | 2023 |
| Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes P Cardoso, KG Young, ATN Nair, R Hopkins, AP McGovern, E Haider, ... Diabetologia 67 (5), 822-836, 2024 | | 2024 |
